Drug Shortage Report for ZYCLARA
Report ID | 237210 |
Drug Identification Number | 02340445 |
Brand name | ZYCLARA |
Common or Proper name | ZYCLARA |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | IMIQUIMOD |
Strength(s) | 3.75% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 7.5g |
ATC code | D06BB |
ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-11-01 |
Actual start date | 2024-11-05 |
Estimated end date | 2025-03-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-07 |
Company comments | delay in production |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-11-07 | French | Compare |
v8 | 2024-11-07 | English | Compare |
v7 | 2024-11-02 | English | Compare |
v6 | 2024-10-23 | French | Compare |
v5 | 2024-10-23 | English | Compare |
v4 | 2024-10-15 | French | Compare |
v3 | 2024-10-15 | English | Compare |
v2 | 2024-09-11 | French | Compare |
v1 | 2024-09-11 | English | Compare |
Showing 1 to 9 of 9